IP lawyers need to keep current with the growing body of case law from the Federal Circuit. Those decisions affect a company's IP portfolio strategy on many levels in significant, and sometimes subtle, ways. Some decisions have particular importance and deserve a closer look.

Please join our panelists as they discuss decisions impacting practice before the Patent Trial and Appeal Board, including the scope of the Board's review and treatment of objective evidence of nonobviousness:

Leo Pharmaceutical Products v. Rea (2013)

  • The Federal Circuit disagreed with the Board's claim construction and reversed its obviousness determination.
  • The Court held that the Board incorrectly found the claimed invention obvious and incorrectly weighed the objective evidence of nonobviousness.

Rambus Inc. v. Rea (2013)

  • The Federal Circuit vacated the Board's decision on obviousness and remanded, finding that the Board committed multiple errors in its decision.
  • The Court found that the Board exceeded its limited role to review the examiner's decision during prosecution, that it made new fact findings, and that it erred in its treatment of objective evidence of nonobviousness.

In re Biedermann (2013)

  • Like Rambus v. Rea, the Federal Circuit vacated the Board's decision and remanded, finding that the Board issued new grounds of rejection when it adopted different reasons to support the examiner's rejection.

The analysis and discussion will be led by seasoned patent practitioners Kathleen Daley and Naveen Modi. Kathleen has significant experience in trial and appellate litigation, having been involved in more than fifty reexamination proceedings and serving as lead counsel before the Patent Trial and Appeal Board in inter partes review proceedings. Naveen practices all aspects of patent-related work, including litigation (U.S. district court, U.S. International Trade Commission, and appellate), client counseling, post-grant proceedings, interferences, patent prosecution, and opinions.

This webinar is the fourth in our 2013 Federal Circuit webinar series. We hope you are able to attend.

Register
There is no charge to attend this program. Please register by
December 4, 2013. Webinar access and dial-in information will be sent upon registration.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.